Trial Profile
Real life study of Siltuximab in relapsed or refractory Multicentric Castleman Disease (MCD) patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2018
Price :
$35
*
At a glance
- Drugs Siltuximab (Primary)
- Indications Giant lymph node hyperplasia
- Focus Adverse reactions; Therapeutic Use
- 02 Dec 2018 New trial record